Cancer Patient Education
Information for patients with cancer. To be used with Altai Oncology Software and Oncology App
No posts were found for provided query parameters.
bendamustine
Bendamustine is a chemotherapy given by IV for certain leukemias and lymphomas. It can lower blood counts and raise the risk of infection and bleeding. Serious reactions can occur,
belzutifan
Belzutifan (Welireg) is a targeted cancer medicine used for some VHL-related tumors, kidney cancer, and certain adrenal and nerve-related tumors. Important risks include harm to an
belinostat
Belinostat (Beleodaq) is an IV chemotherapy used for relapsed or refractory peripheral T-cell lymphoma. It is an HDAC inhibitor that affects how cancer cells grow and die. Key risk
belantamab mafodotin
Belantamab mafodotin (Blenrep) is used for multiple myeloma after other treatments. It can cause serious eye problems, so you will have regular eye exams and should report any visi
azacitidine
Azacitidine is used for certain blood cancers. The injection (Vidaza) treats MDS and AML. The tablet (Onureg) is used for AML and is not approved for MDS. It can lower blood counts
axitinib
Axitinib (brand name Inlyta) is an oral targeted therapy for kidney cancer. It blocks signals that help tumors grow blood vessels, which can slow cancer growth. It can cause high b
glofitamab
Glofitamab (Columvi) is an IV cancer medicine for certain large B-cell lymphomas after other treatments. It can cause serious cytokine release syndrome (CRS), infections, low blood
polatuzumab vedotin-piiq
Polatuzumab vedotin-piiq (brand name Polivy) is used with other medicines to treat certain diffuse large B-cell lymphomas in adults. It targets B cells and delivers a chemotherapy
